Enhanced restriction site mutation (RSM) analysis of 1,2-dimethylhydrazine induced mutations, using endogenous p53 intron sequences

Mutagenesis

Volumn 12, Issue 3, 1997, Pages 117-123

  Jenkins, Gareth J S ^a   Mitchell, Ian De G ^b   Parry, James M ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; PROTEIN P53;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXON; GENE MUTATION; INTRON; MALE; MOUSE; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; SPONTANEOUS MUTATION;

1,2-DIMETHYLHYDRAZINE; ANIMALS; BASE SEQUENCE; BINDING SITES; DIMETHYLHYDRAZINES; DNA PRIMERS; DNA RESTRICTION ENZYMES; EXONS; GENES, P53; INTRONS; MALE; MICE; MUTAGENS; MUTATION; POLYMERASE CHAIN REACTION;

EID: 0030920275     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/12.3.117     Document Type: Article

References (36)

1. Albertini, R.J., Nicklas, J.A., O'Neill, J.P. and Robinson, S.H. (1990) In vivo somatic mutations in humans - measurement and analysis. Ann. Rev. Genet., 24, 305-326.
2. Bohr, V.A. (1985) Gene specific DNA repair. Carcinogenesis, 12, 1983-1992.
3. Cho, Y., Gorina, S., Jeffrey, P.D. and Pavletich, N.P.(1994) Crystal structure of a p53 tumour suppressor-DNA complex: understanding tumourigenic mutations. Science, 265, 346-354.
4. Chiocca, S.M., Sandy, M.S. and Cerutti, P.A. (1992) Genotypic analysis of N-ethyl-N-nitrosourea-induced mutations by TaqI restriction fragment length polymorphism/polymerase chain reaction in the c-H-ras1 gene. Proc. Natl. Acad. Sci., 89, 5331-5335.
5. Felley Bosco, E., Pourzand, C., Zijlstra, J., Amstad, P. and Cerutti, P. (1991) A genotypic mutation system measuring mutations in restriction recognition sequences. Nucleic Acids Res., 19, 2913-2919.
6. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
7. Internation Agency for Research on Cancer (1974) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. No. 4. IARC, Lyon, pp. 145.
8. Jacoby, R.F., Llor, X., Teng, B., Davidson, N.O. and Brasitus, T.A. (1991) Mutations in the K-ras oncogene in preneoplastic and neoplastic rat colonic mucosa. J. Clin. Invest., 87, 624-630.
9. Kennerley, G.A. and Parry, J.M. (1993) Analysis of benzo[a]pyrene induced mutations by the use of Restriction-Site Mutation assays in aquatic species. Mutat. Res., 307, 223-228.
10. Lane, D.P. (1992) Cancer: p53, guardian of the genome. Nature, 358, 15-16.
11. Llor, X., Jacoby, R.F., Teng, B., Davidson, N.O., Sitrin, M.D. and Brasitus, T.A.(1991) K-ras mutations in 1,2-dimethylhydrazine-induced colonie tumours: effects of supplemental dietary cacium and vitamin D deficiency. Cancer Res., 51, 4305-4309.
12. Mellon, I., Spivak, G. and Hanawalt, P.C. (1987) Selective removal of transcription blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell, 51, 241.
13. Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
14. Myers, B.J. and Parry, J.M. (1994)The application of the restriction site mutation assay to the study of mutations in the tissues of rodents. Mutagenesis, 9, 175-177.
15. Nigro, J.M., Baker, S.J., Preisinger, A.C., Jessup, J.M., Hostetter, R., Cleary, K., Bigner, S.H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F.S., Weston, A., Modali, R., Harris, C.C. and Vogelstein, B. (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705-708.
16. 1 hybrid mice. Carcinogenesis, 16, 2659-2666.
17. Parry, J.M., Shamsher, M. and Skibinski, D. (1990) Restriction site mutation analysis, a proposed methodology for the detection and study of DNA base changes following mutagen exposure. Mutagenesis, 9, 209-212.
18. Porcher, C., Maligne, M.-C., Picat, C. and Grandchamp, B. (1992) A simplified method for determination of specific DNA or RNA copy numbers using quantitative PCR and an automated DNA sequencer. Biotechnioques, 13, 106-114.
19. Pourzand, C. and Cerutti, P. (1993) Genotypic mutation analysis by RFLP/ PCR. Mutat. Res., 288, 113-121.
20. Saiki, R., Gelfand, D., Stoffel, S., Scharf, S., Higuchi, R., Horn, G., Mullis, K. and Erlich, H. (1988) Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239, 4877-4891.
21. Sandy, M.S., Chiocca, S.M. and Cerutti, P.A. (1991) Genotypic analysis of mutations in TaqI restriction recognition sites by restricion fragment length polymorphism/polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 89, 890-894.
22. Sangwick, B. (1992) Oxidation of methylhydrazines to mutagenic alkylating derivatives and inducers of the adaptive response of Esherichia coli to alkylation damage. Cancer Res., 52, 3693-3697.
23. Siebert, P.D. and Larrick, J.W. (1992) Competitive PCR. Nature, 359, 557-558.
24. Siebert, P.D. and Larrick, J.W. (1993) PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques, 14, 244-249.
25. 6 alkylation by the N-nitroso carcinogens N-methyl-N-nitrosourea and N-ethyl-N-nitrosourea. Mutat. Res., 250, 153-160.
26. Soussi, T., de Fromental, C. and May, P. (1990) Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5, 945-952.
27. Steingrimsdottir, H., Beare, D., Cole, J., Leal, J.F.M., Kostic, T., Lopez-Barea, J., Dorado, G. and Lehmann, A.R. (1996) Development of new molecular procedures for the detection of genetic alteration in man. Mutat. Res., 353, 109-121.
28. Suzen, H.S. (1996) The Application of Genotypic Analysis to the Study of Environmental Toxicology. PhD thesis, University of Wales.
29. Thurnherr, N., Deschner, E.E., Stonehill, E.H. and Lipkin, M. (1973) Induction of adenocarcinomas of the colon in mice by weekly injections of DMH. Cancer Res., 33, 940-945.
30. Tornaletti, S. and Pfeiffer, G.P. (1994) Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science, 263, 1436-1438.
31. Turker, M.S., Cooper, G.E. and Bishop, P.L. (1993) Region-specific rates of molecular evolution: a fourfold reduction in the rate of accumulation of 'silent' mutations in transcribed versus nontranscribed regions of homologous DNA fragments derived from two closely related mouse species. J. Mol. Evol., 36, 31-40.
32. Turosov, V.S., Lanko, N.S., Parfenov, Y.D., Gordon, G.P., Nelson, S.D., Hillery, P.S. and Keefer, L.K. (1988) Carcinogenicity of deuterium labelled 1,2-dimethylhydrazine in mice. Cancer Res., 48, 2162-2167.
33. Wabl, M., Burrows, P.D., von Gabain, A. and Steinberg, C. (1985) Hypermutation at the immunoglobulin heavy chain locus in a pre-B cell line. Proc. Natl. Acad. Sci., 82, 479-482.
34. Yonisch Rouach, E., Resnitsky, D., Lotem, J., Sachs, A., Kimuchi, A. and Oren, M. (1991) Wild type p53 induced apoptosis of myeloid leukaemic cells that is inhibited by interleukin 6. Nature, 352, 345-347.
35. Zeilmaker, M.J., Horsfall, M.J., van Helten, J.B.M., Glickman, B.W. and Mohn, G.R. (1991) Mutational specificities of environmental carcinogens in the lacI gene of Escherichia coli H.V. DNA sequence analysis of mutations in bacteria recovered from the liver of Swiss mice exposed to 1,2-dimethylhydrazine, azoxymethane and methylazoxymethanolacetate. Mol. Carcinogen., 4, 180-188.
36. Zijlstra, J., Felley Bosco, E., Amstad, P. and. Cerutti, P. (1990) Mutagens and Carcinogens in the Diet. Wiley-Liss, New York, pp. 187-200.